Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Equity Income (2024 - 2025)

Tandem Diabetes Care's Equity Income history spans 2 years, with the latest figure at -$4.6 million for Q4 2025.

  • For Q4 2025, Equity Income fell 116.81% year-over-year to -$4.6 million; the TTM value through Dec 2025 reached -$14.1 million, down 572.76%, while the annual FY2025 figure was -$14.2 million, 575.9% down from the prior year.
  • Equity Income reached -$4.6 million in Q4 2025 per TNDM's latest filing, down from -$2.7 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of -$2.1 million in Q4 2024 to a low of -$4.6 million in Q4 2025.